International Journal of Pancreatology

, Volume 1, Issue 3–4, pp 195–203 | Cite as

Hypertriglyceridaemia and abnormalities of triglyceride catabolism persisting after pancreatitis

  • P. N. Durrington
  • O. P. Twentyman
  • J. M. Braganza
  • J. P. Miller
Research Papers


Thirty-three patients referred consecutively following an attack of pancreatitis at least six weeks earlier (acute pancreatitis in 10 patients and chronic pancreatitis in 23 patients) had an intravenous fat tolerance test to determine their capacity to catabolise circulating triglycerides. Hypertriglyceridaemia was present in 14 patients (42%), including 5 with acute pancreatitis and 9 with chronic pancreatitis. the highest serum triglyceride level was 6.2 mmol/l and none of the patients had chylomicronaemia at the time of examination. Four of the patients with hypertriglyceridaemia had impaired triglyceride clearance (29% of those with hypertriglyceridaemia, representing 12% of the patients as a whole). These four patients were indistinguishable from the others with hypertriglyceridaemia on clinical or routine biochemical grounds. Although triglyceride clearance in the other 10 patients with hypertriglyceridaemia was lower on average (P<0.04) than in the subgroup of patients with normal levels of serum triglycerides, the clearance values were within the normal range and did not correlate with the serum triglyceride levels.

We conclude that an intravenous lipid tolerance test is a useful means of identifying patients with a defect in triglyceride catabolism, who might be vulnerable to a further attack of pancreatitis due to massive hypertriglyceridaemia in certain circumstances. In the majority of patients found to have hypertriglyceridaemia after an attack, the serum lipid disturbance is unlikely to be the direct cause of the attack, but may be an epiphenomenon of some process that is linked to acute and chronic pancreatitis.

Key words

Hypertriglyceridaemia intralipid tolerance pancreatitis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fischer, B. Über lipamie und Cholesteramie, sowie über Veranderungen des Pankreas und der Leber bei Diabetes mellitus, Virchows Arch., 1903; 172: 30–71.CrossRefGoogle Scholar
  2. 2.
    Holt, L.E., Aylward, F.X. and Timbres, H.G. Idiopathic familial lipaemia, John Hopkins Hosp. Bull., 1939; 64: 279–314.Google Scholar
  3. 3.
    Klatskin, G. and Gordon, M. Relationship between relapsing pancreatitis and essential hyperlipaemia, Am. J. Med., 1952; 12: 3–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Fredrickson, D.S., Goldstein, J.L. and Brown, M.S. Familial hyperlipoproteinaemias. In: J.B. Stanbury, J.B. Wyngaarden and D.S. Frederickson (Eds.), The Metabolic Basis of Inherited Disease, 4th ed. McGraw-Hill, New York, 1978: 608–665.Google Scholar
  5. 5.
    Farmer, R.G., Winkelman, E.I., Brown, H.B. and Lewis, L.A. Hyperlipoproteinaemia and pancreatitis, Am. J. Med., 1973; 54: 161–165.PubMedCrossRefGoogle Scholar
  6. 6.
    Cameron, J.L., Capuzzi, D.M., Zuidema, G.D. and Margolis, S. Acute pancreatitis with hyperlipaemia the incidence of lipid abnormalities in acute pancreatitis, Ann. Surg., 1973; 177: 483–489.PubMedCrossRefGoogle Scholar
  7. 7.
    Brunzell, J.D. and Bierman, E.L. Chylomicronaemia syndrome. Interaction of genetic and acquired hypertriglyceridaemia, Med. Clin. N. Am., 1982; 66: 455–468.PubMedGoogle Scholar
  8. 8.
    Havel, R.J. Pathogenesis, differentiation and management of hypertriglyceridaemia, Adv. Intern. Med., 1969; 15: 117–154.PubMedGoogle Scholar
  9. 9.
    Glueck, C.J., Scheel, D., Fishback, J. and Steiner, P. Oestrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproreinaemia, Metabolism, 1972; 21: 657–665.PubMedCrossRefGoogle Scholar
  10. 10.
    Chait, A., Mancini, M., February, A.W. and Lewis, B., Clinical and metabolic study of alcoholic hyperlipidaemia, Lancet 1972; 2: 62–64.PubMedCrossRefGoogle Scholar
  11. 11.
    Cameron, J.L., Capuzzi, D.M., Zuidema, G.D. and Margolis, S., Acute pancreatitis with hyperlipaemia. Evidence for a persistent defect in lipid metabolism, Am. J. Med., 1974; 56: 482–487.PubMedCrossRefGoogle Scholar
  12. 12.
    Rossner, S. Studies on an intravenous fat tolerance test. Methodological, experimental and clinical experiences with Intralipid, Acta. Med. Scand. Suppl., 1974; 564, 1–24.PubMedGoogle Scholar
  13. 13.
    Lewis, B. Laboratory practice, II: lipoproteins and function tests. In: The hyperlipidaemias: Clinical and Laboratory Practice, Blackwell, Oxford, 1976: 400–419.Google Scholar
  14. 14.
    Rossner, S. Further methodological studies on the intravenous fat tolerance with Intralipid emulsion, Scand. J. Clin. Lab. Invest., 1976; 36: 155–159.PubMedCrossRefGoogle Scholar
  15. 15.
    Braganza, J.M. Does your patient have pancreatic disease? J. R. Coll. Phys. 1982; 16: 13–22.Google Scholar
  16. 16.
    Slack, J., Noble, N., Meade, T.W. and North, W.R.S. Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London, Brit. Med. J. 1977; 2: 353–356.PubMedCrossRefGoogle Scholar
  17. 17.
    Durrington, P.N. and Cairns, S.A. Acute pancreatitis: a complication of beta-blockade, Brit. Med. J., 1982; 284: 1016.Google Scholar
  18. 18.
    Fallat, R.W., Vestor, J.W. and Glueck, C.J. Suppression of amylase activity by hypertriglyceridaemia, J. Am. Med. Assoc., 1973; 225: 1331–1334.CrossRefGoogle Scholar
  19. 19.
    Lesser, P.B. and Warshaw, A.L., Diagnosis of pancreatitis masked by hyperlipidaemia. Ann. Intern. Med., 1975; 82: 795–798.PubMedGoogle Scholar
  20. 20.
    Warshaw, A.L., Bellini, C.A. and Lesser, P.B. Inhibition of serum and urine amylase activity in pancreatitis with hyperlipaemia, Ann. Surg., 1975; 182: 72–75.PubMedCrossRefGoogle Scholar
  21. 21.
    Guzman, S., Nervi, F., Llanos, O., Leon, P. and Valdivieso, V. Impaired lipid clearance in patients with previous acute pancratitis, Gut, 1985; 26: 888–891.PubMedCrossRefGoogle Scholar
  22. 22.
    Wang, C., Strauss, L. and Adlersberg, D. Experimental pancreatitis and plasma lipids, Gastroenterology, 1958; 35: 465–472.PubMedGoogle Scholar
  23. 23.
    Stackhouse, K.L., Glass, D.D. and Zimmerman, B. Relationships of lipoprotein lipase and hyperlipaemia in pancreatitis, Surg. Forum, 1966; 17: 343–344.PubMedGoogle Scholar
  24. 24.
    Braganza, J.M. Pancreatic disease: a casualty of hepatic “detoxification”, Lancet 1983; ii: 1000–1003.CrossRefGoogle Scholar
  25. 25.
    Martin, P.J., Martin, J.V. and Goldberg, D.M., γ-Glutamyl transpeptidase, triglycerides and enzyme induction, Br. Med. J., 1975; i: 17–18.Google Scholar
  26. 26.
    Durrington, P.N., Roberts, C.J.C., Jackson, L., Branch, R.A. and Hartog, M. Effect of phenobarbitone on plasma lipids in normal subjects. Clin. Sci. Mol. Med., 1976; 50: 349–353.PubMedGoogle Scholar

Copyright information

© Elsevier Science Publishers B.V. (Biomedical Division) 1986

Authors and Affiliations

  • P. N. Durrington
    • 1
  • O. P. Twentyman
    • 1
  • J. M. Braganza
    • 1
  • J. P. Miller
    • 2
  1. 1.Department of Medicine, Manchester Royal InfirmaryUniversity of ManchesterManchesterU.K.
  2. 2.University Hospital of South ManchesterManchesterU.K.

Personalised recommendations